Spectral AI, Inc. Class A Common Stock
MDAISpectral AI, Inc. Class A (MDAI) is a technology company specializing in spatial data and AI solutions. It develops advanced imaging and sensing technologies to capture, analyze, and interpret complex data for various applications, including defense, security, and industrial sectors. The company focuses on leveraging machine learning and computer vision to provide actionable insights from high-resolution spatial data.
Company News
Spectral AI showcased its DeepView System at the Southern Region Burn Conference, demonstrating its AI technology for objective burn wound assessment. The company aims to improve patient outcomes and reduce healthcare costs through innovative medical diagnostics.
Spectral AI reported a net loss of $3.6 million in Q3 2025, reduced revenue guidance to $18.5 million, and anticipates a flat to slightly lower revenue year in 2026. The company continues to progress towards FDA clearance for its DeepView medical device and is expanding international market presence.
Spectral AI reported Q3 2025 financial results with $3.8 million in research and development revenue, a net loss of $3.6 million, and a strong cash position of $10.5 million. The company continues to progress towards FDA De Novo submission for its DeepView® System in wound care diagnostics.
Spectral AI will report its third quarter 2025 financial results on November 11, 2025, after market close, with a conference call to discuss the results.
Spectral AI, a medical diagnostics AI company, was recognized on TIME's World's Top HealthTech Companies 2025 list for its innovative DeepView technology focused on wound care and burn treatment diagnostics.
